- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
康肾颗粒治疗慢性肾功能衰竭疗效探讨.doc
康肾颗粒治疗慢性肾功能衰竭疗效探讨
摘要:目的:探讨康肾颗粒治疗慢性肾功能衰竭的临床疗效。方法:选取88例患有慢性肾功能衰竭的患者并随机均分为一般治疗组、对照组以及治疗组。一般治疗组采用常规肾衰治疗如降压、纠正酸中毒、纠正贫血等,对照组患者在常规治疗的基础上加用口服尿毒清颗粒进行治疗,治疗组在常规治疗基础上加用口服康肾颗粒进行治疗。对三组患者治疗3个月前后的临床指标变化与临床疗效进行对照比较。结果:三组患者进行治疗3个月后,内生肌酐清除率与血清肌酐水平方面,治疗组与对照组相比无统计学意义(P0.05),此两组患者与一般治疗组相比,差异具有统计学意义(P0.05);临床疗效方面,治疗组优于对照组,两组患者均优于一般治疗组,三组比较差异具有统计学意义(P0.05)。结论:加用康肾颗粒对慢性肾功能衰竭进行治疗后,临床疗效显著,能够有效降低血清肌酐,提高内生肌酐清除率,患者无需增加排便次数,副作用较少,值得临床应用及推广。
关键词:康肾颗粒;血清肌酐;内生肌酐清除率
Discussion of kangshenkeli efficacy in the treatment of chronic renal failure
LinLin ZhuWeiPing ZhengJing
renal Department of internal medicine The Fifth Hospital Affiliated to Zhongshan University Zip code:519000
[Abstract] Objective: To investigate the clinical efficacy of Shenkang granule in the treatment of chronic renal failure. Methods: 88 patients with chronic renal failure were randomly divided into treatment group and control group in general, and the treatment group. The general treatment group with conventional treatment such as blood pressure, renal failure to correct acidosis, correct anemia, patients in control group were treated with oral administration of Niaoduqing particles on the basis of conventional therapy, the treatment group on the basis of conventional therapy, were treated with oral Kang Shen granules. On three groups of patients before and after 3 months of clinical index changes and the clinical effects were compared between. Results: the three groups of patients after 3 months of treatment, endogenous creatinine clearance rate and serum creatinine level, no significant difference in treatment group and the control group (P 0.05), the two groups of patients compared with the normal group, the difference was statistically significant (P 0.05); clinical curative effect, treatment group than the control group, two patients in treatment group were superior to the general, the difference between the three groups was significant (to have statistical significance (P 0.05)). Conclusion: combined wit
原创力文档


文档评论(0)